Delivery Order SPE2DB22D3102-SPE2DB25FL3AS
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 17, 2025, for Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $3,414.70. This firm fixed price delivery order, with an ultimate completion date of June 18, 2025, represents a single-unit transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, for Lantus SoloStar 100 Unit/mL 3mL insulin products. This firm fixed-price contract, valued at $1,218.64, represents a competitive award with no set-aside designation and is scheduled for completion by September 26, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,068.40 by the Defense Logistics Agency (DLA) on April 22, 2025, with an ultimate completion date of April 23, 2025. The delivery order is for Lantus SoloStar 100 Unit/mL 3mL insulin pens, a diabetes medication supplied on a firm fixed price basis with no set-aside designation. This award represents a competitive, non-set-aside transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.88 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,770.53 for Lantus SoloStar 100 Unit/mL 3mL insulin pens on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 12, 2025. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a ceiling value of $1,397.48. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to complete by May 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a $2,045.86 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $4,038.26 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 13, 2025, with an ultimate completion date of June 16, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lantus SoloStar insulin 100 unit/mL in 3 mL pens. This non-set-aside, competitively awarded contract carries a ceiling value of $2,171.76 with firm fixed pricing and an ultimate completion date of August 4, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL3ASDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for Lantus SoloStar 100 Unit/mL insulin pens with a ceiling value of $1,022.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's comprehensive global pharmaceutical support vehicle with DLA, which enables the company to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts covering diverse therapeutic domains including diabetes management medications and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/16/25 |